Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Par Acquisition By TPG Allows Competing Marriage Proposals

Jul 16 2012

• By Lisa LaMotta

Related Content

Par Gets Pumped: Teva To Divest $200 Million Of Products To Acquire Cephalon

Oct 11 2011

Generic Opportunities In 2012 Diluted By Shared Exclusivities

Jan 23 2012

Related Companies

Par Pharmaceutical Companies Inc.

Endo, Inc.

Cephalon, Inc.

Teva Pharmaceutical Industries Ltd.

Allergan plc

Novartis AG

Novartis AG

Allergan plc

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Momenta Pharmaceuticals, Inc.

Additional Topics

Deals BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window